Cagent Vascular Announces FDA 510(k) Clearance for its Serranator Device for the Infrapopliteal Indication and Completion of its PRELUDE-BTK Clinical Trial Enrollment - Business Wire
[unable to retrieve full-text content] NAVIGATING THE SILENCE: RECONSIDERING TREATMENT PARADIGMS IN ASYMPTOMATIC SEVERE AORTIC STENOSIS ScienceDirect.com
[unable to retrieve full-text content] High arrhythmic risk in antero-septal acute myocardial ischemia is explained by increased transmural reentry occurrence | Scientific Reports Nature
Comments
Post a Comment